Yuki Miyai
Tracked across 1 events · 7 articles · First seen Jul 23, 2026 · Last active Aug 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Researchers at Nagoya University in Japan discovered that complement C3 protein, when produced locally within tumors, prevents immunosuppressive myeloid cells from infiltrating the tumor microenvironment, thereby enhancing the efficacy of cancer immunotherapy. The findings, published…
Impact: As lead author, Yuki Miyai's work is central to the discovery, potentially boosting his academic standing and opening new research opportunities.
Jul 23, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Yuki Miyai live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard